Jump to content

Biomedical


These projects build on the multi-functionality allowed by 2DMs to demonstrate the advantages of combining e.g. biocompatibility, chemical stability, (bio-) sensing and actuating, and integration with flexible electronic technologies, in addition to versatile surface chemistry (for interface with biology) which allows for continuous health monitoring and built-in pharmacological interventions.

The aim is to offer new technology solutions exploiting the unique properties of 2D materials (2DM) that would reduce cost and increase the efficacy of diagnostics or therapies, or provide new diagnostics or therapies for which there is currently no solution. It would strengthen Europe’s industrial position in, early diagnostics, disease prediction and prevention, disease monitoring and reducing hospitalization time.

Projects

2D-BioPAD


2D-BioPAD is a cost-effective, non-invasive point of care/self-testing tool for the early and accurate prognosis (assistive diagnosis) of Alzheimer's Disease, with special focus on earlier stages such as Subjective or Mild Cognitive Impairment (SCI/MCI).

MORPHEUS


The MORPHEUS (MOdular Reconfigurable Platform for Health and Environmental Universal Sensing) project is developing a wearable patch capable of integrating various sensors that, in the future, could enable continuous monitoring of physiological and biochemical parameters, such as blood pressure, temperature, glucose and cortisol, in hospitalised patients.

MUNASET


Proteases recently emerged as a promising new class of biomarkers with a broad diagnostic, prognostic and therapeutic potential for different human diseases including neurological and psychiatric diseases, several types of cancer, and immune system disorders. However, there is a lack of tools for real-time activity analysis of disease-related protease biomarkers.

STAND


The STAND project – Sensing Textiles enabled with Advanced Novel materials for Diabetic foot care – aims to design and develop a wearable system that continuously monitors key indicators such as pressure, temperature and humidity. By combining advanced materials, flexible electronics and data analysis, the Smart Sock will be able to detect early signs of risk supporting timely intervention and reducing the likelihood of ulcers and complications.

Latest articles

artificial retina
Biomedical / Innovation / Milestones

Graphene oxide added to the composition of the liquid artificial retina: A further step toward clinical trials


Graphene Flagship partner, the Istituto Italiano di Tecnologia, together with IRCCS Azienda Ospedaliera Metropolitana – Policlinico San Martino Hospital, has demonstrated that graphene oxide—used for the first time in the ophthalmic field—enhances the liquid artificial retina, increasing light sensitivity and recovery of visual function in advanced stages of retinitis pigmentosa. The study, published in Nature Communications, led to the restoration of electrical activity in the visual cortex, bringing this strategy closer to future clinical trials in humans.

By Graphene Flagship / 13 May 2026
Show all news